CervoMed Inc
CRVO
Market Cap$118.44M
Close$
$12.85
93.5% upside
Current Fair Value
93.5% upsideUndervalued by 93.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $118.44 Million |
|---|---|
| Enterprise Value | $109.80 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.82 |
| Beta | 0 |
| Outstanding Shares | 8,702,764 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -24.76 |
|---|---|
| PEG | -26.16 |
| Price to Sales | - |
| Price to Book Ratio | 2.21 |
| Enterprise Value to Revenue | 33.38 |
| Enterprise Value to EBIT | -5.24 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About CervoMed Inc
18 employeesdiffusion pharmaceuticals is a clinical stage company focused on improving the effectiveness of standard-of-care therapies for life-threatening treatment-resistant solid cancerous tumors, without adding harmful side effects. the company ...